Background Dilated cardiomyopathy (DCM) is distinguished by left ventricle (LV) dilation
accompanied by systolic dysfunction. However, some studies suggested also a high …

Background It is commonly accepted that myocardial fibrosis (MF) is implicated in the
pathology of dilated cardiomyopathy (DCM). However, MF is not a “fixed” abnormality but …

Background Prognostic value of myocardial fibrosis in patients with non-ischemic idiopathic
dilated cardiomyopathy (DCM) is not well-defined. We sought to assess the association of …

Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

Background Mitochondrial damage is associated with histologic myocardial fibrosis. Late
gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) can be used to …

Background Accumulating evidence indicates that myocardial fibrosis contributes to the
pathogenesis of diastolic dysfunction. However, investigating this issue has long been …

Background: To prospectively examine the dynamic evolution of fibrotic processes within a
one-year in patients with dilated cardiomyopathy (DCM). Methods: Between May 2019 and …

Purpose: Non-ischemic dilated cardiomyopathy (DCM) is characterized by fibrotic changes
beyond myocite vacualization and nuclear abnormalities. While the diagnostic value of …

Background Increased myocardial fibrosis may play a key role in heart failure with preserved
ejection fraction (HFpEF) pathophysiology. The study aim was to evaluate the presence …